Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease

Neurotoxicity Research

Volumn 21, Issue 2, 2012, Pages 143-148

  Brus, Ryszard ^a,b   Jochem, Jerzy ^a   Nowak, Przemysław ^a,b   Adwent, Marta ^a,b   Boroń, Dariusz ^a   Brus, Halina ^a   Kostrzewa, Richard M ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b High School of Strategic Planning   (Poland)

^c East Tennessee State University   (United States)

Author keywords

6 Hydroxydopamine; Brain; Histamine; Manganese; Rats

Indexed keywords

DESIPRAMINE; DOPAMINE; DRINKING WATER; HISTAMINE; MANGANESE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN LEVEL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HISTAMINE RELEASE; INTOXICATION; MALE; MEDULLA OBLONGATA; NEUROTOXICITY; NEWBORN; NONHUMAN; ONTOGENY; PARKINSON DISEASE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; DRINKING WATER; FEMALE; HISTAMINE; MALE; MANGANESE; MATERNAL EXPOSURE; OXIDOPAMINE; PARKINSONIAN DISORDERS; PREGNANCY; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 84856494303     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9251-1     Document Type: Article

References (58)

1. +3. Neurodegeneration 2:329-334
2. Anichtchik OV, Rinne J, Kalimo H, Panula P (2000) An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 163:20-30 (Pubitemid 30314356)
3. Archibald FS, Tyre C (1987) Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys 256:638-650 (Pubitemid 17128522)
4. Aschner M, Kimelberg HK (1996) Astrocytes: potential modulators of heavy metal-induced neurotoxicity. In: Chang LW (ed) Toxicology of metals. Lewis Publisher, London, pp 587-608
5. Barceloux DG (1999) Manganese. Clin Toxicol 37:293-307 (Pubitemid 29292913)
6. Berger TW, Kaul S, Stricker EM, Zigmond MJ (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res 336:354-358 (Pubitemid 15008390)
7. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D (2007) Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect 115:122-127 (Pubitemid 46050293)
8. Brus R, Kostrzewa RM, Perry KW, Fuller RW (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 260:231-237 (Pubitemid 24039093)
9. Brus R, Nowak P, Sokoła A, Labus L, Oswicimska J, Winiarska H, Kostrzewa RM, Shani J (2002a) Exposure of pregnant rats to manganese: effect on levels, turnover and release of biogenic amines in brains of their offspring. Pharmacol Rev Commun 12:61-75 (Pubitemid 34693012)
10. Brus R, Szkilnik R, Konecki J, Stepien M, Malecki S, Kuballa G, Mengel K, Shani J (2002b) Prenatal exposure of rats to manganese: changes in reactivity of their central dopaminergic, serotoninergic and muscrine receptors, but not of glucose uptake in their adult offsprings. Pharmacol Rev Commun 12:9-24 (Pubitemid 34693009)
11. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W (1994) Mechanism and idiopathic parkinsonism: similarities & differences. Neurology 44:1583-1586 (Pubitemid 24286629)
12. Chan AW, Minski MJ, Lim L, Lai JC (1992) Changes in brain regional during postnatal development: modulations by chronic manganese administration. Met Brain Dis 7:21-33
13. Chandra SV, Shukla GS, Srivastava RS, Singh H, Gupta VP (1981) Exploratory study of manganese exposure to welders. Clin Toxicol 18:407-416 (Pubitemid 11085497)
14. Cochlo MH, Silva IJ, Azevedo MS, Manso CF (1991) Decrease in blood histamine in drug-treated Parkinsonian patients. Mol Chem Neuropathol 14:77-85
15. Cook DG, Fahn S, Brait KA (1974) Chronic manganese intoxication. Arch Neurol 30:59-64
16. Cotzias GC, Papavasilion PS, Ginos J, Stechk A, Duby S (1971) Metabolic modification of Parkinson's disease and chronic manganese poisoning. Annu Rev Med 22:305-336
17. Davids E, Zhang K, Tarazi FI, Baldessarini RJ (2003) Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 42:1-21 (Pubitemid 36369262)
18. Davidson L, Cederblad A, Lonnerdal B, Sandstrom B (1989) Manganese absorption from human milk, cow's milk and infant formulas in humans. Am J Dis Child 143:823-827 (Pubitemid 19172103)
19. Desole MS, Esposito G, Migheli R, Fresu L, Sireana S, Miele M, De-Natale G, Miele E (1995) Allopurinol protects against manganese-induced oxidative stress in striatum and in the brainstem of the rat. Neurosci Lett 192:73-76
20. Donaldson J (1987) The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8:451-462 (Pubitemid 18018069)
21. Farias AC, Cunha A, Benko CR, McCracken JT, Costa MT, Farias LG, Cordeiro ML (2010) Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure. J Child Adolesc Psychopharmacol 20:113-118
22. Gennart JP, Buchet JP, Roels H, Ghyselen P, Ceulemans E, Lauwerys R (1992) Fertility of male workers exposed to cadmium, lead, or manganese. Am J Epidemiol 135:1208-1219
23. Ingersoll RT, Montgomery EBJr, Aposhian HV (1995) Central nervous system toxicity of manganese. I. Inhibition of spontaneous motor activity in rats after intrathecal administration of manganese chloride. Fundam Appl Toxicol 27:106-113
24. Inoue N, Makita Y (1996) Neurological aspects in human exposure to manganese. In: Chang LW (ed) Toxicology of metals. Lewis Publisher, London, pp 415-438
25. Jochem J (2004) Involvement of the sympathetic nervous system in the reversal of critical haemorrhacic hypotension by endogenous central histamine in rats. Naunyn Schmiedebergs Arch Pharmacol 369:418-427 (Pubitemid 38553677)
26. Kontur PJ, Fechter LD (1985) Brain manganese, catecholamine turnover and the development of startle in rats prenatally exposed to manganese. Teratology 32:1-11 (Pubitemid 15033530)
27. Kontur PJ, Fechter LD (1988) Brain manganese, catecholamine turnover, and the development of startle in rats prenatally exposed to manganese. Neurotoxicol Teratol 10:295-303 (Pubitemid 19267567)
28. Kostrzewa RM (2001) Mechanism of action of 6-hydroxydopamine, a dopaminergic neurotoxin. In: Segura-Aguilar J (ed) Mechanisms of degeneration and protection of the dopaminergic system. FP Graham Publishing Co., Johnson, pp 89-104
29. Kostrzewa RM, Gong L, Brus R (1992) Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiol Exp 53:31-41
30. Kostrzewa RM, Brus R, Kalbfleisch JH, Perry KW, Fuller RW (1994) Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34:161-167 (Pubitemid 24125414)
31. Kostrzewa RM, Reader TA, Descarries L (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J Neurochem 70:889-898 (Pubitemid 28113620)
32. Kostrzewa RM, Kostrzewa JP, Brus R, Kostrzewa RA, Nowak P (2006) Proposed animal model of severe Parkinson's disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum. J Neural Transm Suppl 70:277-279 (Pubitemid 44622212)
33. Kostrzewa RM, Kostrzewa JP, Kostrzewa RA, Nowak P, Brus R (2007) Pharmacological models of ADHD. J Neural Transm 115:287-298
34. Lai JC, Leung TK, Lim L, Chan AW, Minski MJ (1991) Effect of chronic manganese treatment on rat brain regional sodium-potassium-activated and magnesium-activated adenosine-triphosphatase activities during development. Metab Brain Dis 6:165-174
35. Liu LL, Yang J, Lei GF, Wang GJ, Wang YW, Sun RP (2008) Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. Basic Clin Pharmacol Toxicol 102:527-532 (Pubitemid 351691961)
36. Magnusson O, Nilsson LB, Westerland D (1980) Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatansts from brain tissue homogenates in a liquid chromatography-electrochemical detection system. J Chromatogr 221:237-247 (Pubitemid 11185001)
37. Mena I, Marin O, Fuenzalida S, Cotzias GC (1967) Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17:128-136
38. Mena I, Kazuko H, Burke K, Cotzias GC (1969) Chronic manganese poisoning: individual susceptibility and absorption of iron. Neurology 19:1000-1006
39. Mendes-Alvares E, Soto-Otero R, Hermida-Ameijeiras A, Lopez-Martin ME (2001) Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants. Free Radic Biol Med 31:986-998 (Pubitemid 32939394)
40. Nowak P, Noras Ł, Jochem J, Szkilnik R, Brus H, Korossy E, Drab J, Kostrzewa RM, Brus R (2009) Histaminergic activity in a rodent model of Parkinson's disease. Neurotox Res 15:246-251
41. Nowak P, Bojanek K, Szkilnik R, Jośko J, Boroń D, Adwent M, Gorczyca P, Kostrzewa RM, Brus R (2011) Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine. Neurotox Res 19(4):536-543
42. Panula P, Airaksinen MS, Pirvola U, Kotilainen E (1990) A histamine-containing neuronal system in human brain. Neuroscience 34:127-132 (Pubitemid 20097900)
43. Pentschew W, Ebner FF, Koratch RM (1963) Experimental manganese encephalopathy in monkeys. J Neuropathol Exp Neurol 22:488-499
44. Prell GD, Green JP (1991) Histamine metabolites and pros- methylimidazoleacetic acid in human cerebrospinal fluid. Agents Actions Suppl 33:343-363
45. Rinne JO, Aniehtchik OV, Errikson KS, Kaslin L, Tuomisto L, Kalimo H, Röytta M, Panula P (2002) Increase brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 81:954-960 (Pubitemid 34811944)
46. Rodier J (1955) Manganese poisoning in Moroccan miners. Br J Ind Med 12:21-35
47. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Rant M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71:1-51
48. Seth PK, Husain R, Mishtag M, Chandro SV (1997) Effect of manganese on neonatal rat: manganese concentration and enzymatic alterations in brain. Acta Pharmacol Toxicol 40:553-560
49. Shaywitz BA, Yager RD, Klopper JH (1976) Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191:305-308
50. Sloot WN, Gramsbergen JB (1994) Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 657:124-132
51. Sloot WN, van der Sluijs-Gelling AJ, Gramsbergen JB (1994) Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. J Neurochem 62:205-216
52. Sloot WN, Korf J, Koster JF, De Wit LE, Gramsbergen JB (1996) Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion. Exp Neurol 138:236-245 (Pubitemid 26132711)
53. Snyder AM, Zigmond MJ, Lund RD (1986) Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol 245:274-281 (Pubitemid 16163314)
54. Tanaka S, Lieben J (1969) Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 19:647-684
55. Tarohda T, Ishida Y, Kawai K, Yamamoto M, Amano R (2005) Regional distributions of manganese, iron, copper and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats. Anal Bioanal Chem 383:224-234 (Pubitemid 41442914)
56. Wada H, Inagaki N, Itowi N, Yamatodani A (1991) Histaminergic neuron system in the brain: distribution and possible functions. Brain Res Bull 27:367-370
57. Wagner J, Vitali P, Palfreyman MG, Zraika M, Hout S (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-MPA, NE, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-HIAA in rat cerebrospinal fluid and brain by HPLC. J Neurochem 38:1241-1254 (Pubitemid 12091482)
58. Witholt R, Gwiazda RH, Smith DR (2000) The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism. Neurotox Teratol 22:851-861